Scandiatransplant Waiting List Denmark 1995-2006 James Heaf.

Slides:



Advertisements
Similar presentations
This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
Advertisements

This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non- commercial study and educational.
This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Scottish Renal Registry Report 2009 Section B - PREVALENCE Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland,
Dialysis vs Transplant: the Australia & New Zealand experience Stephen McDonald ANZDATA Registry Adelaide, South Australia.
This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
Admission Patterns for Danish ESRD Patients DNS National Register and National Patient Register merged 9317 patients 232,760 admissions 167,217.
ANZDATA Registry Annual Report 2013 Philip Clayton CHAPTER 9 KIDNEY DONATION 2013 Annual Report - 36th Edition TRANSPLANT WAITING LIST CHAPTER 7.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
UK Renal Registry 17th Annual Report Figure 9.1. Median height z-scores for transplant patients
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
ESRD Prognosis ERA-EDTA vs. Danish Renal Registry James Heaf.
© ANZOD Registry International Donor Statistics 1997 % of Multiple Organ Donors Donors PMP % Mult. Donors Eurotransplant:Germany, Austria, Belgium, Luxembourg,
CORR Report, 2012: CST Annual General Meeting S. Joseph Kim, MD, PhD, FRCPC Vice President, CORR Board of Directors Friday, February 24,
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
A Guide to the Scientific Registry of Transplant Recipients Organ Procurement Organization Reports
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
Recurrence of Malignancy after Transplantation ANZDATA - Australian and New Zealand Dialysis and Transplant Registry NSW Cancer Council.
1. THE START OF THE PROCESS
UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.
UK Renal Registry 10th Annual Report 2007 Fig 10.1 Summary of BP achievements.
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
Fioretti S.; Antik A; Busto S; Bacque MC; Schiavelli R; Domenech A; Vallejos A. Analysis of Kidneys Procured by the Transplant Institute and DGF in Transplant.
Chapter 10 Cancer 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013 ANZDATA gratefully acknowledges the contributions of the Cancer Working.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
VCA Donation: legal framework and NEOB experience Alexandra K. Glazier, JD MPH VP & General Counsel New England Organ Bank.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
HEART-LUNG TRANSPLANTATION Pediatric Recipients 2015 JHLT Oct; 34(10):
ESRD Prognoses James Heaf. This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used.
UK Renal Registry 15th Annual Report Figure 7.1. Median height z-scores for transplant patients
Scottish Renal Registry Report 2009 Section D - Kidney Transplantation Published by the Information Services Division (ISD Scotland), Common Services Agency.
Parathyroidectomy Danish Renal Registry James Heaf.
Dansk Nefrologi James Heaf2, Søren Schwartz Sørensen, Karin Skov3, Eirild Espersen3, Claus Bistrup4 Rigshospitalet, Herlev Hospital, Aarhus Universitetshospital,
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 15th Annual Report
UK Renal Registry 16th Annual Report
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 18th Annual Report
Renal transplants in Scandiatransplant
RENAL TRANSPLANT ALLOCATION IN KZN
ORGAN TRANSPLANTATION
Liver only transplants in the UK Question 2: In terms of survival benefit.
HEART TRANSPLANTATION
Human Blood Types Exist because there are three proteins that can be found on human red blood cells: A protein B protein Rh Factor [if it’s present, the.
HEART TRANSPLANTATION
Risk factors in deceased-donor transplants Risk factor 1988
Living donor liver transplantation: is the hype over?
Prolonged warm ischemia time is associated with graft failure and mortality after kidney transplantation  Karthik K. Tennankore, S. Joseph Kim, Ian P.J.
UK Renal Registry 13th Annual Report
Fig 6.1 Frequency of ischaemic heart disease in incident patients
Renal Association UK Renal Registry.
UK Renal Registry 16th Annual Report
Graphs from annual report 2018
UK Renal Registry 14th Annual Report
Renal Association UK Renal Registry.
Donor-recipient matching: Myths and realities
The Danish Renal Biopsy Register
Volume 143, Issue 5, Pages (November 2012)
Renal Association UK Renal Registry.
UK Renal Registry 9th Annual Report 2006
Renal Association UK Renal Registry.
Presentation transcript:

Scandiatransplant Waiting List Denmark James Heaf

This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational purposes. Any commercial use or publication requires the prior permission of the Danish Renal Registry.

Waiting List Duration and Transplant Frequency Excluding living donors

Waiting List Fate and Cohort (1)

Waiting List Fate and Cohort (2)

Median Waiting Time: Transplant Center and Cohort

Age and Transplantation

Waiting List, Age and Diagnosis

Transplantation, Age and Diagnosis

Blood Group Distribution Denmark O A B AB

Short Blood Group Waiting List: Possible Causes ”Pool Advantage”: fewer recipients than expected More living donors than expected Living donor transfers from other groups More dead donors than expected Dead donor transfers from other groups

Net Blood Group Transfers A O B AB O B A Dead Donors Living Donors 0.4% 0.1% 0.5% 0.1%0.2% 12.7% 1.9% 0% 4.2% 1.3% % of Blood Group Donor Pool

Blood Group B Observed-Expected Pool Advantage = % Expected in Recipient pool - % Observed

Renal Diagnosis and Blood Group B Frequency

Blood Group AB Observed-Expected Pool Advantage = % Expected in Recipient pool - % Observed

Waiting List Duration and Immunisation Living Donors Excluded

Risk Factors for Death

Blood Group O Observed-Expected Pool Advantage = % Expected in Recipient pool - % Observed

Blood Group A Observed-Expected Pool Advantage = % Expected in Recipient pool - % Observed

Nontransplanted Waiting List Patients